Olivier Langlois

Rouen, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 41 publications

Characteristics, outcome, and prognostic factors of young patients with central nervous system World Health Organization grade 3 oligodendrogliomas IDH-mutant and 1p/19q codeleted: A French POLA network study.

Characteristics, outcome, and prognostic factors of young patients with central nervous system World Health Organization grade 3 oligodendrogliomas IDH-mutant and 1p/19q codeleted: A French POLA network study.

Journal: Cancer

Published: November 30, 2024

The clinical impact of EGFR alterations in elderly glioblastoma patients: results from a real-life cohort.

The clinical impact of EGFR alterations in elderly glioblastoma patients: results from a real-life cohort.

Journal: Journal of neuro-oncology

Published: October 03, 2024

Survival Outcomes Associated With First-Line Procarbazine, CCNU, and Vincristine or Temozolomide in Combination With Radiotherapy in IDH-Mutant 1p/19q-Codeleted Grade 3 Oligodendroglioma.

Survival Outcomes Associated With First-Line Procarbazine, CCNU, and Vincristine or Temozolomide in Combination With Radiotherapy in IDH-Mutant 1p/19q-Codeleted Grade 3 Oligodendroglioma.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: October 02, 2024

Metabolic remodeling in glioblastoma: a longitudinal multi-omics study.

Metabolic remodeling in glioblastoma: a longitudinal multi-omics study.

Journal: Acta neuropathologica communications

Published: July 07, 2024

Prognostic value of circulating short-length DNA fragments in unresected glioblastoma patients.

Prognostic value of circulating short-length DNA fragments in unresected glioblastoma patients.

Journal: Translational oncology

Published: November 09, 2023

Impact of Covid-19 pandemic on neuro-oncology multidisciplinary tumor board in the pre-vaccine era: the Normandy experience.

Impact of Covid-19 pandemic on neuro-oncology multidisciplinary tumor board in the pre-vaccine era: the Normandy experience.

Journal: Neuro-Chirurgie

Published: February 08, 2023

Characteristics, Patterns of Care and Predictive Geriatric Factors in Elderly Patients Treated for High-Grade IDH-Mutant Gliomas: A French POLA Network Study.

Characteristics, Patterns of Care and Predictive Geriatric Factors in Elderly Patients Treated for High-Grade IDH-Mutant Gliomas: A French POLA Network Study.

Journal: Cancers

Published: September 17, 2022

Impact of EGFRA289T/V mutation on relapse pattern in glioblastoma.

Impact of EGFRA289T/V mutation on relapse pattern in glioblastoma.

Journal: ESMO open

Published: September 12, 2022

Incidence and characteristics of pseudoprogression in IDH-mutant high-grade gliomas: A POLA network study.

Incidence and characteristics of pseudoprogression in IDH-mutant high-grade gliomas: A POLA network study.

Journal: Neuro-oncology

Published: August 11, 2022

Microsurgical Clipping of Middle Cerebral Artery Aneurysms: Complications and Risk Factors for Complications.

Microsurgical Clipping of Middle Cerebral Artery Aneurysms: Complications and Risk Factors for Complications.

Journal: World neurosurgery

Published: July 12, 2022

Characteristics of Anaplastic Oligodendrogliomas Short-Term Survivors: A POLA Network Study.

Characteristics of Anaplastic Oligodendrogliomas Short-Term Survivors: A POLA Network Study.

Journal: The oncologist

Published: June 10, 2021

Targeting the Urotensin II/UT G Protein-Coupled Receptor to Counteract Angiogenesis and Mesenchymal Hypoxia/Necrosis in Glioblastoma.

Targeting the Urotensin II/UT G Protein-Coupled Receptor to Counteract Angiogenesis and Mesenchymal Hypoxia/Necrosis in Glioblastoma.

Journal: Frontiers in cell and developmental biology

Published: January 12, 2021

Showing 1-12 of 41

Last Updated: 09/26/2026